Member Type: Diagnostic Companies
Personal Genome Diagnostics (PGDx) provides advanced cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company uses its deep expertise in cancer biology and advanced genomic methods to identify and characterize the unique genomic alterations in liquid and tissue biopsies. PGDx’s CLIA certified facility offers a range of high-complexity molecular testing including whole genome, exome, targeted and single gene analyses. PGDx developed and introduced a number of novel methods to study plasma and tissue samples, including methods for advanced bioinformatics analysis.